News
QuantifiCare and Legit.Health Launch the First AI-Powered Dermatology Imaging Platform for Clinical Trials
The strategic partnership combines QuantifiCare’s world-leading imaging expertise with Legit.Health’s leading AI to speed up the development of new therapies in dermatology. Biot, France and Bilbao, Spain – 08/28/2025 – In a major step forward for dermatology...
Quantificare Announces Transition to LifeViz Neo
February 17, 2025 – Quantificare Headquarters Quantificare Announces Transition to LifeViz Neo Quantificare is entering a new era of innovation with LifeViz Neo! As of February 17, 2025, LifeViz App will no longer be maintained. For customers who are no longer under...
QuantifiCare v. Canfield Scientific: German Federal Supreme Court Upholds QuantifiCare’s LifeViz® Infinity Patent
September 18, 2024 QuantifiCare v. Canfield Scientific: German Federal Supreme Court Upholds QuantifiCare’s LifeViz® Infinity Patent On July 23, 2024, the German Federal Supreme Court confirmed the validity of the German part of QuantifiCare’s European patent 3 156...
LifeViz® Mini Pro Awarded Best Aesthetic Device 2024
QuantifiCare’s LifeViz® Mini Pro Awarded Best Aesthetic Device 2024 Monaco / March 27th 2024 At QuantifiCare, we are thrilled to announce that our dedication to innovation and excellence has been recognized once again. We have proudly received the Best Aesthetic...
Major Legal Victory for QuantifiCare: Düsseldorf Court Confirms Patent Infringement by Canfield’s Vectra H2 System
April 23, 2025 Major Legal Victory for QuantifiCare: Düsseldorf Court Confirms Patent Infringement by Canfield's Vectra H2 System. QuantifiCare, a global leader in imaging solutions, has achieved a significant legal victory in its ongoing effort to defend its...
QuantifiCare and Nikon: Building the Future of Imaging Technology Together
QuantifiCare is excited to strengthen its collaboration with Nikon, a world leader in imaging and photography technology. For over 15 years, we have built innovative 2D and 3D camera solutions, including the groundbreaking 3D LifeViz system, on the trusted...
QuantifiCare Featured in Prime Journal: Showcasing Innovation in Aesthetic Technology
We are thrilled to announce that QuantifiCare has been featured in the latest issue of Prime Journal, a leading publication for aesthetic medicine professionals. The article highlights the cutting-edge technology behind our 3D LifeViz® systems, with a special focus on...
LifeViz Infinity Pro Awarded Best Aesthetic Device
QuantifiCare’s LifeViz Infinity Pro Awarded Best Aesthetic Device Monaco / April 1st 2022 Following the successful launch of its premium, new 3D Aesthetic photography system, QuantifiCare was awarded the Best Aesthetic Device for the LifeViz® Infinity Pro at...
A Legacy of Excellence: QuantifiCare Wins “Best Aesthetic Device” for the 6th Time with DermaViz UV
Monaco, March 27, 2025 – QuantifiCare is proud to announce that the new DermaViz UV has been awarded the prestigious Best Aesthetic Device award in 2025, marking our 6th distinction in 10 years of innovation. This year, among more than 1,000 applications, 220...
Revolutionizing Medical Imaging: QuantifiCare partners with Inria, i3S (CNRS) and Hosteur to Advance AI innovations to Improve Health Outcomes
Sophia Antipolis, October 23rd, 2024 - QuantifiCare SA, a pioneering company based in Sophia Antipolis and internationally renowned for its expertise in 2D/3D medical imaging and clinical research, is proud to announce the establishment of an AI Consortium in...
LifeViz® Micro Featured in Groundbreaking Clinical Study on Sleep Wrinkles Reduction
We are excited to announce that QuantifiCare’s innovative 3D LifeViz® Micro system has been prominently featured in a clinical study published in Anti-Âge journal. The study, led by Dr. Sara Gómez-Armayones from Corium Dermatology Clinic, in collaboration with the...
3D LifeViz® in Nature Magazine Report
3D LifeViz ® recognized as the most objective means of evaluation for laser treatments in Nature Magazine Report.